Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Commentary.
Features of Human CD3+CD20+ T Cells.
Best Practices for Network Meta-Analysis Methodology: Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis.
Whole Transcriptome Screening Reveals Myelination Deficits in Dysplastic Human Temporal Neocortex.
Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis.
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
[Cormorbidity in multiple sclerosis and its therapeutic approach].
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.
Newer multiple sclerosis drugs and disability scores - are key data analyses missing?
Degradation of polyomavirus JC T-antigen by stress involves the LIP isoform of C/EBP.
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study.
Rabies encephalomyelitis vs. ADEM: Usefulness of MR imaging in differential diagnosis.
Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Factors affecting bone mineral density in multiple sclerosis patients.
Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs).
Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
A possible case of acute disseminated encephalomyelitis after Japanese encephalitis.
Month of birth and the incidence of multiple sclerosis in southern iran.
Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro.
Pages
« first
‹ previous
…
554
555
556
557
558
559
560
561
562
…
next ›
last »